肌少症对肝内胆管结石患者手术结局的影响:多中心10年经验
本研究纳入2010至2020年6家中心因肝内胆管结石行半肝切除术的患者,分析肌少症及肌少症性肥胖对术后短期结局的影响,并比较不同手术方式的获益。结果显示肌少症患者术后住院时间、进食时间、排便时间及下床活动时间更长,主要并发症、胆漏及ICU占用率更高;肌少症性肥胖亚组结局最差。肌少症患者可从腹腔镜手术获益,非肥胖肌少症患者获益更显著。
要点
- 肌少症增加肝内胆管结石半肝切除术后不良结局风险。
- 肌少症性肥胖患者术中及术后短期结局最差。
- 肌少症患者可从腹腔镜手术获益,非肥胖者获益更明显。
核心结论
- 肌少症与肝内胆管结石半肝切除术后更多不良事件相关,肌少症性肥胖患者不良事件发生率更高。
- 肌少症患者可从腹腔镜手术获益,非肥胖肌少症患者较肌少症性肥胖患者获益更显著。
- 肌少症性肥胖患者腹腔镜手术可改善短期结局,但需要更长学习曲线。
研究设计与样本
- 多中心回顾性研究,纳入2010至2020年福建某医院及另外5家中心因肝内胆管结石行半肝切除术的患者。
- 肌少症组481例,其中肌少症性肥胖亚组182例,非肥胖肌少症亚组299例。
主要发现
- 肌少症患者术后住院时间、经口进食时间、排便时间及下床活动时间均长于非肌少症患者。
- 肌少症患者主要并发症、胆漏及ICU占用率高于非肌少症组。
- 肌少症性肥胖亚组术中及术后短期结局最差。
- 多因素分析显示肌少症性肥胖是术后住院时间的显著危险因素(HR=2.994,P<.001)。
- 肌少症性肥胖和非肥胖肌少症亚组均从腹腔镜手术获益,包括术后恢复和主要并发症(均P<.05),但非肥胖肌少症亚组获益更显著。
关键数值与推荐
- 肌少症性肥胖定义为肌少症合并肥胖,非肥胖肌少症定义为肌少症不合并肥胖。
- 多因素分析中肌少症性肥胖对术后住院时间的HR=2.994,P<.001。
- 腹腔镜手术获益比较中,术后恢复和主要并发症的P值均<.05。
临床怎么用
- 对肝内胆管结石拟行半肝切除术的患者,应评估肌少症及肥胖状态以预判手术风险。
- 肌少症患者可优先考虑腹腔镜手术,尤其非肥胖肌少症患者。
- 肌少症性肥胖患者腹腔镜手术需注意学习曲线,术后恢复可能较慢。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The impact of sarcopenia on the surgical outcomes of hepatectomy for hepatolithiasis has not been investigated. The present study elucidated the effect of sarcopenia on short-term outcomes after hemihepatectomy for hepatolithiasis and investigated the benefit of different surgical approaches to hepatectomy in patients with sarcopenia. METHODS: Patients who underwent hemihepatectomy for hepatolithiasis at Fujian Provincial Hospital and 5 other medical centers from 2010 to 2020 were enrolled. The sarcopenic obesity subgroup had sarcopenia coexisting with obesity, and the sarcopenic nonobesity subgroup had sarcopenia without obesity. We analyzed the postoperative outcomes of the sarcopenia group, sarcopenic obesity subgroup and sarcopenic nonobesity subgroup and the corresponding benefits of different surgical approaches. RESULTS: Patients with sarcopenia (n = 481) had worse surgical outcomes than nonsarcopenia, such as longer postoperative hospital duration of stay, longer time to oral intake, longer time to bowel movement, and longer time to off-bed activities. In postoperative short-term outcomes, we also found that sarcopenia had higher rates of major complications, bile leakage, and intensive care unit occupancy than the nonsarcopenic group. Subgroup analysis showed that sarcopenic obesity subgroup (n = 182) had the worst results in intraoperative outcomes and postoperative short-term outcomes. Multivariate analysis identified sarcopenic obesity as a significant risk factor for postoperative hospital duration of stay (hazard ratio = 2.994, P < .001). Furthermore, the sarcopenic obesity and sarcopenic nonobesity (n = 299) subgroups benefited from laparoscopic surgery compared with open surgery, including postoperative recovery and major complications (all P < .05). However, sarcopenic nonobesity subgroup had more significant benefits of laparoscopy than the sarcopenic obesity subgroup. The learning curve for laparoscopic hemihepatectomy for the sarcopenic obesity subgroup had a plateau, and the surgical outcomes of the sarcopenic obesity subgroup were closer to the sarcopenic nonobesity subgroup after the plateau. CONCLUSION: Sarcopenia is associated with more adverse events after hepatectomy and patients with sarcopenic obesity have a higher incidence of adverse events. Patients with sarcopenia could benefit from laparoscopy. Compared with the sarcopenic obesity patients, the sarcopenic nonobesity patients benefited more from laparoscopy. Although the sarcopenic obesity patients had more complications and slower postoperative recovery than the sarcopenic nonobesity patients, laparoscopic also could improve their short-term outcomes, but a longer learning curve was required.
引用
- Wang T, Chen X, Liao C, et al. Impact of sarcopenia on the surgical outcomes in patients with hepatolithiasis: A multicenter 10-year experience. Surgery. 2022. PMID: 36280506. doi:10.1016/j.surg.2022.09.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。